Table 4

Estimates of titers of neutralizing antibodies required for sterile protection against HIV.

Investigator

Titer

SN

End Point

Species

Remarks


Trkola et al [58]

1/200

70%

Human

Acute infection

Parren et al [60]

1/400

90%

Macaques

SHIV Challenge

Nishimura et al. [61]

1/38

100%

Macaques

SHIV Challenge

Mascola et al [50,52]

1/50, 1/29–1/88

90%

Macaques

SHIV Challenge

Trkola et al [59]

1/400

90%

Human

Rebound after HAART


Plotkin Journal of the International AIDS Society 2009 12:2   doi:10.1186/1758-2652-12-2

Open Data